30.06.2010
- Sanofi-Aventis is to buy U.S. biotech TargeGen, which is developing treatments against blood diseases, for as much as $560 million as part of the French drugmaker's drive to boost...
30.06.2010
- EU farm ministers failed to agree on Tuesday to approve six genetically modified (GM) maize varieties for import to the bloc, despite a warning that inaction could lead to a...
18.06.2010
- DSM BioSolutions has announced that it has entered into an agreement with Novacta Biosystems, Welwyn Garden City, UK, for the process development and cGMP production of its C...
10.06.2010
- DSM BioSolutions today announced that it has entered into an agreement with Novacta Biosystems, Welwyn Garden City, UK, for the process development and cGMP production of its C...
10.06.2010
- BASF, one of the world's largest chemical companies, is investing more in its biotech crop technology unit, pushing a raft of new products to market that should start contributing...
31.05.2010
- Ubichem, a provider of chemistry services to the drug development sector, through its Hungarian operation - Ubichem Research - has successfully completed a regulatory inspection...
27.05.2010
- Europe's economic jitters will clean out the health-science industry, leaving global generic as well as innovative drugmakers among the survivors, the head of Swiss drugmaker Roche...
27.05.2010
- Top Pfizer research executive Martin Mackay has left the world's biggest drugmaker to head research at rival AstraZeneca as both companies brace for patent expirations on their top...
26.05.2010
- Israel's Teva Pharmaceutical Industries is developing a generic version of Roche's blockbuster antibody drug Rituxan, highlighting the race to produce so-called biosimilar...
18.05.2010
- IP Protection - In the pharmaceutical industry, the discovery of a new compound is often just the beginning of a series of inventions. During various steps of the development...
